Tobramycin Inhalation Powder™: a novel drug delivery system for treating chronicPseudomonas aeruginosainfection in cystic fibrosis
Author:
Publisher
Informa UK Limited
Subject
Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Immunology and Allergy
Link
http://www.tandfonline.com/doi/pdf/10.1586/ers.11.56
Reference129 articles.
1. Update in Cystic Fibrosis 2008
2. Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
3. Respiratory Microbiology of Patients With Cystic Fibrosis in the United States, 1995 to 2005
4. Microbiology of airway disease in a cohort of patients with Cystic Fibrosis
5. MucoidPseudomonas aeruginosa is a marker of poor survival in cystic fibrosis
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Advanced pulmonary drug delivery formulations for the treatment of cystic fibrosis;Drug Discovery Today;2023-10
2. Recent Approach in Microbial Pathogen Complications in Patients with Cystic Fibrosis;Cystic Fibrosis - Heterogeneity and Personalized Treatment;2020-07-08
3. Drugs for Gram-Negative Bugs From 2010–2019: A Decade in Review;Open Forum Infectious Diseases;2020-07-01
4. Ciprofloxacin Dry Powder for Inhalation (ciprofloxacin DPI): Technical design and features of an efficient drug–device combination;Pulmonary Pharmacology & Therapeutics;2018-06
5. Effect of pH and leucine concentration on aerosolization properties of carrier-free formulations of levofloxacin;European Journal of Pharmaceutical Sciences;2018-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3